News
Innovative Medical and Pathology Laboratories in Canada Shared Successes in Improving Patient Outcomes at Last Week’s Executive Edge Conference
Canada's largest innovation conference on the management and operations of medical laboratories was held in Toronto, Ontario this month to a sold out crowd. Dr Jelena Holovati, Aline Gagnon, Christine Nielsen and Kathy Wilkie participated in a panel discussion that DarkDaily calls "one of the most spirited sessions at Executive Edge". Each of the panelists shared a common understanding and voiced their opinion on the ability of Canada to produce more graduates. This message reflected the national need for increased support and active engagement of laboratories and hospitals to provide quality clinical placement experiences for students that match the educational and human health resource needs of our profession. Among the many valuable sessions, additional presentations provided insight into Lean methodology and multi-disciplinary collaborative strategies within and outside the lab, the national genomic initiative, and impact of new technologies.
In addition to the DarkDaily article, read the Executive Edge 2015 Program for further details.
Beyond the Biohazard Door: It's time to open the lines of communication between lab professionals and nurses
Inter-professional communication and practice has become a hot topic over recent years. Lucinda Manning, BA, MT(ASCP), RN, assistant vice president and group manager of blood services at ARUP Laboratories is an individual who wears two professional hats. Her career began in a hospital-based lab and moved to nursing thereafter. The experience and knowledge garnered from working on both sides of the ‘hospital hallways’ has provided her with a genuine understanding of why nurses and lab professionals communication doesn’t always match up. Manning identifies two main professional differences that lead to communication misunderstandings: difference in practice (e.g., flexibility and adaptability of routine tasks based on in-the-moment patient driven needs versus highly regulated policies and procedures for laboratory testing) and differences in patient contact (e.g., increased participant interaction may provide a “false sense” of authority to change labels versus strict labeling guidelines in the lab). What is the solution? The suggestion to fix these issues has a foundation in communication and education, from the student to administration. "Get laboratory professionals on the patient care floors and get the nurses into the laboratory," said Manning. "Get upper management involved in pushing for a cohesive patient-care team that involves all departments."
Related Publication: Beard, T., Robertson, T., Semler, J., & Cude, C. (2015). A Study of interprofessional collaboration in undergraduate medical laboratory science and nursing education. Clinical Laboratory Science, 28(2), 83-90.
Related Article: Working with Nurses to Make Our Systems Safer
Discovery center: Medical lab techs play crucial role in patient diagnosis
Key Quote: "In a way, it's kind of like we're on the assembly line and we're putting in that one piece that determines whether or not the patient gets help or not," he says. "But the good thing is that it's a win-win for our patients. Granted, no one wants to find out that they're sick, but if the results indicate something, then their path to recovery begins. If the results are negative, then a patient will have less to deal with in the next few days or weeks. Both sets of results have different but positive outcomes."
Summary: In the United States, about half of all medical laboratory technologists and technicians are employed in hospitals while others work in doctors' offices or diagnostic laboratories. Read the story of Donald Solarski, a clinical laboratory technologist who has worked for various Chicagoland medical groups.
AHS extends Dynalife lab services contract one year - Edmonton - CBC News
Health Minister Sarah Hoffman previously announced that the Alberta government would not continue with a proposed plan to expand private laboratory services in Edmonton as a looming contract deadline lay in the background. Alberta Health Services was required to cancel the request for proposals on a $3-billion laboratory contract awarded last year to Sonic (an Australian company).
Two months after the contract was canceled, Alberta Health Services has announced that they have extended their contract with Dynalife Diagnostic Laboratory Services by one year. "This agreement gives confidence to patients and health care providers that this very important health care service will continue without disruption," said AHS CEO Vickie Kaminski in a news release.
Quality
AACC Welcomes Enhanced Role for Laboratory Medicine Experts to Combat Potentially Devastating Diagnostic Error
The National Academy of Medicine released a comprehensive report titled, "Improving diagnosis in health care", which examines the effects of diagnostic error on patients and potential solutions to help deter such situations. The report found that diagnostic errors contribute to approximately 10% of patient deaths. In addition, most individuals will experience at least one diagnostic error in their lifetime. The American Association for Clinical Chemistry (AACC) released a statement on their support for this report and improving the diagnostic process.
“AACC strongly supports initiatives to improve patient care by reducing diagnostic errors and the cost, suffering, and loss of life that stems from these errors. We fully agree with the National Academies that taking a team approach to the diagnostic process is central to accomplishing this goal, and laboratory medicine professionals will be a key player on any successful team,” said AACC President David D. Koch, PhD.
Full Publication: National Academies of Science, Engineering, and Medicine (2015). Improving diagnosis in health care. Washington, DC: The National Academies Press.
Clinical Chemistry
Ammonia and Hyperammonemia | A blog for medical laboratory professionals
Laboratory testing for ammonia is often problematic as contamination can occur from a number of sources including atmospheric ammonia, smoking and poor venipuncture technique. In addition if the sample is not centrifuged and analyzed promptly, ammonia is formed by the continuous deamination of amino acids and the concentration increases by 20% in the first hour and up to 100% by 2 hours. Consequently samples to be tested for ammonia should be placed on ice immediately after being collected and transported to the lab for analysis as soon as possible.
Hematology
Study: Bacterium That Causes Q Fever Linked to Non-Hodgkin Lymphoma
The American Society of Hematology’s journal Blood, published a study that concluded there is an increased risk of lymphoma when Q fever is contracted (animal to human infectious disease). Patients with Q fever were 25 times more likely to develop diffuse large B-cell lymphoma than non-infected individuals. For those with persistent infections concentrated to one area, they were also more likely to develop lymphoma as well.
In order to better understand the association between Coxiella burnetii (the bacterium that causes Q fever) and lymphoma, the study investigators screened 1,468 patients treated for Q fever between 2004 and 2014. In addition to the mentioned conclusions, it was also observed that Q fever patients with lymphoma demonstrate an overproduction of the critical anti-inflammatory pathway interleukin-10 (IL-10). The authors suggest that “the suppression of the immune system may have allowed the lymphoma cells to evade immune detection and multiply”.
Transfusion Medicine
UBC researchers create self-propelled powder to stop bleeding
In a press release from the University of British Columbia, it was announced that researchers from the university had published an article in Science Advances on the creation of “the first self-propelled particles capable of delivering coagulants against the flow of blood to treat severe bleeding, a potentially huge advancement in trauma care” see video. In an interdisciplinary team, a group of researchers, biochemical engineers and emergency physicians developed gas-generating calcium carbonate micro-particles. The particles work by releasing carbon dioxide gas to propel them toward the source of bleeding, which is consistent with how antacid tablets work. Although the possible uses for such an invention are endless especially in powder format, the researchers have a keen interest for use in patients with postpartum bleeding (the powder can target bleeds that cannot be seen), and for use in the emergency room or combat situations is suggested as highly valuable.
Microbiology
Collaborative study for a rapid diagnostic test for Ebola Virus Disease by BIOASTER and FUJIFILM Corporation
Key Quote: "Serving major challenges in health is at the heart of our mission and we are proud to contribute to the fight against the devastating Ebola Virus. Diagnostic is a very critical step in this fight and the argentic amplification technology developed by FUJIFILM is a promising approach to detect the presence of the virus with results in three to fifteen minutes. We are very enthusiast to work with FUJIFILM in translating this technology for the detection of EVD. We are also very excited to conduct this new project with our first partner in Asia” states Nathalie Garçon, Chief Executive and Scientific Officer at BIOASTER.
Summary: BIOASTER, Microbiology Technology Institute, announced that it has confirmed and started a collaboration for the study of an Ebola Virus Disease (EVD) rapid diagnostic system with FUJIFILM Corporation. The joint study aims at establishing a simple, rapid, small-size and portable diagnostic system, with high diagnostic capabilities, comparable to molecular testing.
Official Press Release: Collaborative study for a rapid diagnostic test for Ebola Virus Disease by BIOASTER and FUJIFILM Corporation
Safety
Disease lab staff had no safety training: report
The JC Wilt Infectious Diseases Research centre at Canada's National Microbiology Laboratory, in Winnipeg, Manitoba handles some of the world's most lethal pathogens and has won praise for developing an Ebola virus vaccine and drug treatment. However, in an unfortunate documented incident in 2012, it was identified that a lab worker and supervisor received little safety training before the employee was infected with a disease he had handled. The lab technician recovered shortly after the contamination. Since this time, the pending investigation determined a lack of formal or mandatory safety instruction in the lab, which has been rectified. Sylwia Krzyszton, a Public Health Agency of Canada spokeswoman, stated “The health and safety of our employees is a top priority... There have been no laboratory acquired infections since that time.”
Thank you!
We appreciate that you have taken the time to read LabBuzz. This is a new CSMLS venture to provide relevant medical laboratory news to its members.
We need your help to grow this newsletter! Please pass along the subscription link to any colleague you think would benefit from hearing about med lab news.
If you have any suggestions to improve LabBuzz, we would love to hear from you. In fact, if you have a news or publication link you would like us to consider for a future issue, please send it to labbuzz@csmls.org.